20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BISOPROLOL FUMARATE USP, with a corresponding US DMF Number 18781.
Remarkably, this DMF maintains an Active status since its submission on September 12, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 01, 2019, and payment made on January 28, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II